Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-115-6 | CAS number: 103-47-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016-06-23
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 438 (Isolated Chicken Eye Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- 26 July 2013
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU method B.48 (Isolated chicken eye test method for identifying occular corrosives and severe irritants)
- Version / remarks:
- 08 December 2010
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- 2-(cyclohexylamino)ethanesulphonic acid
- EC Number:
- 203-115-6
- EC Name:
- 2-(cyclohexylamino)ethanesulphonic acid
- Cas Number:
- 103-47-9
- Molecular formula:
- C8H17NO3S
- IUPAC Name:
- 2-(cyclohexylamino)ethanesulphonic acid
- Test material form:
- solid: particulate/powder
Constituent 1
Test animals / tissue source
- Species:
- chicken
- Strain:
- other: ROSS 308
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: Chicken heads for obtained from TARAVIS KFT, 9600 Sárvár, Rábasömjéni út 129, Hungary
- Age at study initiation: eyes for approx. 2 hours old (after head removal)
- Weight at study initiation: not relevant
SOURCE OF COLLECTED EYES
- Source: TARAVIS KFT. 9600 Sárvár, Rábasömjéni út 129. Hungary
- Number of animals: not specified
- Characteristics of donor animals: not specified
- Storage, temperature and transport conditions of ocular tissue: within 2 hours from collection at ambient temperature of 19.4 ºC to 20.3 ºC, heads were wrapped with paper moistened with saline, then placed in a plastic box that can be closed (4-5 heads/box)
- Time interval prior to initiating testing: not specified
- indication of any existing defects or lesions in ocular tissue samples: No. Eyes with a high baseline fluorescein staining (i.e., > 0.5) or corneal opacity score (i.e., > 0.5) were rejected. Any eye with cornea thickness deviating more than 10 % from the mean value for all eyes, or eyes that showed any other signs of damage, were rejected and replaced.
- Indication of any antibiotics used: not specified
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount applied: 0.03 g (per eye)
CONTROLS
- Amount applied: 0.03g Imidazole (positive control) or 30 µL NaCl (in saline; negative control) per eye - Duration of treatment / exposure:
- 10 seconds
- Duration of post- treatment incubation (in vitro):
- 4 hours
- Number of animals or in vitro replicates:
- 3 eyes (test substance and positive control)
1 eye (negative control) - Details on study design:
- SELECTION AND PREPARATION OF ISOLATED EYES
After removing the head from the plastic box, it was put on soft paper. The eyelids were carefully cut away with scissors, avoiding damaging the cornea. One small drop of fluorescein solution 2 (w/v) % was applied onto the cornea surface for a few seconds and subsequently rinsed off with 20 mL isotonic saline. Then the fluorescein-treated cornea was examined with hand-held slit lamp or slit lamp microscope, with the eye in the head, to ensure that the cornea was not damaged. If the cornea was in good condition, the eyeball was carefully removed from the orbit.
The eyeball was carefully removed from the orbit by holding the nictitating membrane with a surgical forceps, while cutting the eye muscles with bent scissors without cutting off the optical nerve too short. The procedure avoided pressure on the eye in order to prevent distortion of the cornea and subsequent corneal opacity. Once removed from the orbit, the eye was placed onto damp paper and the nictitating membrane was cut away with other connective tissue. The prepared eyes were kept on the wet papers in a closed box so that the appropriate humidity was maintained.
EQUILIBRATION AND BASELINE RECORDINGS
The prepared eye was placed in a steel clamp with the cornea positioned vertically with the eye in the correct relative position (same position as in the chicken head). Again avoiding too much pressure on the eye by the clamp. Because of the relatively firm sclera of the chicken eyeball, only slight pressure was applied to fix the eye properly. The clamp with the eyeball was transferred to a chamber of the superfusion apparatus. The clamp holding the eye was positioned in such a way that the entire cornea was supplied with saline solution dripping from a stainless steel tube, at a rate of approximately 3 to 5 drops/minutes. The door of the chamber was closed except for manipulations and examinations, to maintain temperature and humidity.
The appropriate number of eyes was selected and after being placed in the superfusion apparatus, the selected eyes were examined again with the slit lamp microscope to ensure that they were in good condition. The focus was adjusted to see clearly the isotonic saline which was flowing on the cornea surface. Eyes with a high baseline fluorescein staining (i.e., > 0.5) or corneal opacity score (i.e., > 0.5) were rejected. The cornea thickness was measured using the depth measuring device on the slit lamp microscope (Haag-Streit BQ 900) with the slit-width set at 9½, equalling 0.095 mm. Any eye with cornea thickness deviating more than 10 % from the mean value for all eyes, or eyes that showed any other signs of damage, were rejected and replaced. If the selected eyes were appropriate for the test, acclimatization started and was conducted for approximately 45 to 60 minutes. The temperature was verified to be in the range of 32 ± 1.5 °C in all chambers during the acclimatization and treatment periods.
At the end of the acclimatization period, a zero reference measurement was recorded for cornea thickness and opacity to serve as a baseline (t=0) for each individual eye. The cornea thickness of the eyes should not change by more than ±5-7 % within approximately 45 to 60 minutes before the start of application. Changes in thickness were not observed in the eyes. Following the equilibration period, the fluorescein retention was measured. Baseline values were required to evaluate any potential test item related effects after treatment. The location of any minor findings was marked on the record sheet as a drawing, if applicable. If any eye was considered to be unsuitable following baseline assessment, it was discarded.
OBSERVATION PERIOD
The control and test eyes were evaluated pre-treatment and at approximately 30, 75, 120, 180 and 240 minutes after the post-treatment rinse. Minor variations within ± 5 minutes were considered acceptable.
The cornea thickness and cornea opacity were measured at all time points. Fluorescein retention was determined at baseline (t=0) and 30 minutes after the post-treatment rinse.
REMOVAL OF TEST SUBSTANCE
- Volume and washing procedure after exposure period: The time of application was monitored, then after an exposure period of 10 seconds from the end of the application the cornea surface was rinsed thoroughly with approximately 20 mL saline solution at ambient temperature, while taking care not to damage the cornea but attempting to remove all the residual test item if possible. The eye in the holder was then returned to its chamber. The time while the eye was out of the chamber was limited to the minimum.
Imidazole and test item were stuck on the corneas’ surface in all eyes at 30 minutes after the post-treatment rinse. The gentle rinsing with 20 mL saline was performed in all Imidazole treated eyes after the 30, 75, 120 and 180 minutes of observation, but cornea surfaces were not totally cleared at 240 minutes after the post-treatment rinse.
The gentle rinsing with 20 mL saline was performed in all (three eyes) test item treated eyes after the 30 and 75 of observation. All test item treated eyes were totally cleared at 120 minutes after the post-treatment rinse.
METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: was performed
- Damage to epithelium based on fluorescein retention: One small drop of fluorescein solution 2 (w/v) % was applied onto the cornea surface for a few seconds and subsequently rinsed off with 20 mL isotonic saline. Then the fluorescein-treated cornea was examined with hand-held slit lamp or slit lamp microscope.
- Swelling: depth measuring device on the slit lamp microscope (Haag-Streit BQ 900) with the slit-width set at 9½, equalling 0.095 mm
- Macroscopic morphological damage to the surface: was performed
- Others: no histopathology evaluation was performed
SCORING SYSTEM:
based on the OECD guideline.
DECISION CRITERIA: the decision criteria as indicated in the TG was used.
Results and discussion
In vitro
Resultsopen allclose all
- Irritation parameter:
- percent corneal swelling
- Run / experiment:
- mean up to 75 and 240 min
- Value:
- 0
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 0 and 0
- Positive controls validity:
- valid
- Remarks:
- 23 and 26
- Irritation parameter:
- cornea opacity score
- Run / experiment:
- mean
- Value:
- 0.2
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 0.0
- Positive controls validity:
- valid
- Remarks:
- 4.0
- Irritation parameter:
- fluorescein leakage
- Run / experiment:
- mean
- Value:
- 0.5
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 0.0
- Positive controls validity:
- valid
- Remarks:
- 3.0
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: none
DEMONSTRATION OF TECHNICAL PROFICIENCY: -
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes
- Acceptance criteria met for positive control: yes
- Range of historical values if different from the ones specified in the test guideline: not applicable
Any other information on results incl. tables
Table 1: Results for the test item
Observation |
Value |
ICE Class |
Mean maximum corneal swelling at up to 75 min |
0% |
I |
Mean maximum corneal swelling at up to 240 min |
0% |
I |
Mean maximum corneal opacity |
0.2 |
I |
Mean fluoresin retention |
0.5 |
I |
Other Observations |
None |
|
Overall ICE class |
3xI |
Table 2: Results for positive control Imidazole
Observation |
Value |
ICE Class |
Mean maximum corneal swelling at up to 75 min |
23% |
III |
Mean maximum corneal swelling at up to 240 min |
26% |
III |
Mean maximum corneal opacity |
4.0 |
IV |
Mean fluoresin retention |
3.0 |
IV |
Other Observations |
Cornea opacity score 4 was observed in three eyes at 75 minutes after the post-treatment rinse. |
|
Overall ICE class |
1xIII, 2xIV |
The positive control Imidazole was classed as corrosive/severely irritating, UN GHS Classification: Category 1.
Table 3: Results for the negative control NaCl (9 g/L saline)
Observation |
Value |
ICE Class |
Mean maximum corneal swelling at up to 75 min |
0% |
I |
Mean maximum corneal swelling at up to 240 min |
0% |
I |
Mean maximum corneal opacity |
0.0 |
I |
Mean fluoresin retention |
0.0 |
I |
Other Observations |
None |
|
Overall ICE class |
3xI |
Based on the overall ICE Class the negative control NaCl (9 g/L saline) had no significant effects on the chicken eye in this study.
Positive and negative control values were within the corresponding historical control data ranges.
Table 4: Historical control data of Positive control (Period of 2011 - 2015)
IMIDAZOLE HISTORICAL CONTROL Dose level: 30 mg / eye
n=168 |
Relative |
Corneal thickness |
Corneal opacity score |
Fluorescein retention |
||||||||||
30 |
75 |
120 |
180 |
240 |
|
30 |
75 |
120 |
180 |
240 |
|
∆FR |
||
Maximium |
swelling (%): |
34 |
45 |
49 |
54 |
55 |
Max. OS: |
4.0 |
4.0 |
4.0 |
4.0 |
4.0 |
Max. FR: |
3.0 |
Minimum swelling (%): |
3 |
9 |
12 |
14 |
15 |
Min. OS: |
2.8 |
3.3 |
3.5 |
3.5 |
3.5 |
Min. FR: |
2.7 |
|
Average: |
19 |
27 |
31 |
35 |
37 |
Average: |
3.7 |
3.9 |
3.9 |
3.9 |
3.9 |
Average: |
3.0 |
Table 5: Historical control data of Negative control (Period of 2011 - 2015)
NaCl (9 g/L saline) SOLUTION HISTORICAL CONTROL Dose level: 30 µL / eye
n=120 |
Relative |
Corneal thickness |
Corneal opacity score |
Fluorescein retention |
||||||||||
30 |
75 |
120 |
180 |
240 |
|
30 |
75 |
120 |
180 |
240 |
|
∆FR |
||
Maximum |
swelling (%): |
3 |
3 |
3 |
4 |
3 |
Max. OS: |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
Max. FR: |
0.5 |
Minimum swelling (%): |
0 |
0 |
0 |
0 |
0 |
Min. OS: |
0 |
0 |
0 |
0 |
0 |
Min. FR: |
0.0 |
|
Average: |
0.1 |
0.3 |
0.3 |
0.3 |
0.3 |
Average: |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Average: |
0.0 |
Remark:
n = number of examined eyes
∆FR = Difference between fluorescein retention and fluorescein retention reference value
OS = Opacity score
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this in vitro eye corrosive and severe irritant study, using the Isolated Chicken Eye model with the test item, no ocular corrosion or severe irritation potential was observed.
- Executive summary:
An Isolated Chicken Eye Test (ICET) according to OECD 438 was used to evaluate the potential ocular corrosivity and irritancy of the test item by its ability to induce toxicity in enucleated chicken eyes. The test item was applied in a single dose (30 mg/eye) onto the cornea of isolated chicken eyes and rinsed after 10 seconds with saline. Tested corneas were evaluated pre-treatment and at approximately 30, 75, 120, 180, and 240 minutes after the post-treatment rinse. The endpoints evaluated were corneal opacity, swelling, fluorescein retention, and morphological effects. All of the endpoints, with the exception of fluorescein retention (which was determined only at pre-treatment and 30 minutes after test substance exposure) were determined at each of the above time points.
The Imidazole (positive control) was ground before use in the study. The test item and positive control were applied in an amount of 30 mg/eye by powdering the entire surface of the cornea attempting to cover the cornea surface uniformly with the test substance or positive control. Three test item treated eyes and three positive control eyes were used in this study.
One negative control eye was treated with 30 μL saline solution.
After an exposure period of 10 seconds from the end of the application the cornea surface was rinsed thoroughly with approximately 20 mL saline solution at ambient temperature and this procedure was repeated for each eye.
In this ICET, the test item did not cause ocular corrosion or severe irritation in the enucleated chicken eyes. The overall ICE class was 3xI.
Positive and negative controls showed the expected results. The experiment was considered to be valid.
In this in vitro eye corrosive and severe irritant study, using the Isolated Chicken Eye model with the test item, no ocular corrosion or severe irritation potential was observed. The overall ICE score was 3xI.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
